Results 391 to 400 of about 315,545 (404)

Fighting neurodegeneration with rapamycin: mechanistic insights

Nature Reviews Neuroscience, 2011
Miquel Vila
exaly  

Investigation of rapamycin and rapamycin metabolites

2001
openaire   +1 more source

Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance

Cancer Cell, 2006
Ronald W Stam, Joseph T Opferman, Monique L Den Boer   +2 more
exaly  

mTOR: from growth signal integration to cancer, diabetes and ageing

Nature Reviews Molecular Cell Biology, 2010
Roberto Zoncu, Alejo Efeyan, David M Sabatini   +2 more
exaly  

Rapamycin

2011
openaire   +1 more source

Targeting Apoptosis Pathways in Cancer Therapy

Ca-A Cancer Journal for Clinicians, 2005
exaly  

Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin

Cancer Cell, 2006
Janice A Nagy, Kenneth Walsh, David M Briscoe   +2 more
exaly  

Randomized Phase II Study of Multiple Dose Levels of CCI-779, a Novel Mammalian Target of Rapamycin Kinase Inhibitor, in Patients With Advanced Refractory Renal Cell Carcinoma

Journal of Clinical Oncology, 2004
Michael B Atkins, Manuel Hidalgo, Walter M Stadler   +2 more
exaly  

Mammalian Target of Rapamycin Signaling in Cardiac Physiology and Disease

Circulation Research, 2014
Sebastiano Sciarretta, Massimo Volpe
exaly  

Immunosuppressive Profile of Rapamycin

Annals of the New York Academy of Sciences, 1993
openaire   +2 more sources